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Abstract
Rabies in bats is considered enzootic throughout the New World, but few comparative data are available for most countries
in the region. As part of a larger pathogen detection program, enhanced bat rabies surveillance was conducted in
Guatemala, between 2009 and 2011. A total of 672 bats of 31 species were sampled and tested for rabies. The prevalence of
rabies virus (RABV) detection among all collected bats was low (0.3%). Viral antigens were detected and infectious virus was
isolated from the brains of two common vampire bats (Desmodus rotundus). RABV was also isolated from oral swabs, lungs
and kidneys of both bats, whereas viral RNA was detected in all of the tissues examined by hemi-nested RT-PCR except for
the liver of one bat. Sequencing of the nucleoprotein gene showed that both viruses were 100% identical, whereas
sequencing of the glycoprotein gene revealed one non-synonymous substitution (302T,S). The two vampire bat RABV
isolates in this study were phylogenetically related to viruses associated with vampire bats in the eastern states of Mexico
and El Salvador. Additionally, 7% of sera collected from 398 bats demonstrated RABV neutralizing antibody. The proportion
of seropositive bats varied significantly across trophic guilds, suggestive of complex intraspecific compartmentalization of
RABV perpetuation.
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Introduction
Bats (Order: Chiroptera) have been implicated as hosts and
reservoirs for numerous emerging infectious diseases, and are
considered one of the most relevant groups of mammals in the
study of disease ecology [1]. Guatemala is home to some of the
world’s richest bat biodiversity, with over 104 extant species [2–4].
As one representative global disease detection site established by
the U.S. Centers for Disease Control and Prevention, enhanced
rabies surveillance and pathogen discovery over the past five years
targeting bats has facilitated the discovery of numerous novel viral
and bacterial agents [5–8]. Considering the diversity and zoonotic
potential of pathogens detected to date, the most pressing zoonotic
threat from bats in Guatemala is Rabies virus (RABV), the only
Lyssavirus documented in the New World [9]. Rabies is defined
clinically in humans that present with an acute progressive
encephalitis dominated by hyperactivity or paralytic syndromes
that eventually deteriorate towards coma and death in nearly
100% of cases [10].
Rabies epizootiology is well appreciated in countries with an
established laboratory-based surveillance network. Combined with
molecular epidemiology, enhanced and passive surveillance are
used to define the geographic distribution of RABV variants, infer
the temporal and spatial spread of infections associated with
diverse reservoir hosts, identify spillover infections into humans,
and to devise relevant prevention and control based upon such
information [11–13]. Generally, RABV can be divided into two
major clades: one comprising variants associated with carnivores
around the globe, and another containing variants associated
with bats, raccoons and skunks in the New World. In Latin
America, RABV is classically recognized as two broadly distinct
epizootiological forms or ‘cycles’, one ‘urban’, in which dogs
may serve as the primary reservoir host and vector, and the
other as a so-called rural or ‘sylvatic’ cycle, involving wildlife
[13].
RABV transmitted by vampire bats (Desmodus rotundus)
represents the most apparent economic and public health threat
associated with bats [14]. Vampire bats exist only in Latin
America, and range from the Tropic of Cancer in Mexico, to the
Tropic of Capricorn in Argentina and Chile [15]. Vampire bats
include three monotypic genera, and all three species derive
nutrition from feeding on the blood of other vertebrates. A
consequence of this unique biological adaptation is that vampire
bats are highly effective at transmitting RABV to a wide diversity
of mammals, primarily livestock, but also humans, if preferred
prey are not widely available [16]. In Latin America, human
rabies fatalities have been associated with RABV spillover from
frugivorous and insectivorous bats. However, the burden of
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mortality appears negligible compared to the human rabies
burden associated with the common vampire bat [17–19].
Laboratory-based surveillance is recommended by the World
Health Organization in all RABV enzootic countries. Accurate
ongoing prevalence measures are essential in rabies prevention
and control, to estimate the burden of disease, to monitor trends to
evaluate the effectiveness of case intervention, and to ensure
appropriate management of outbreaks [20]. The surveillance
system for rabies in Guatemala is passive, where samples from
suspected human and animal cases are collected, sent, and tested
by the direct fluorescent antibody (DFA) test at one of two
laboratories: the Laboratorio Nacional de Salud in Villa Nueva
(main facility), or Laboratorio de Ministerio de Agricultura,
Ganaderı´a y Alimentacio´n (MAGA) in Quetzaltenango. The
number of reported human rabies cases has decreased over the
past two decades. Dogs remain the primary RABV vector, and are
associated with approximately 73% (44 of 60) of human cases from
1994 to 2012. However, 23% (14 of 60) of these cases were due to
an unspecified or unknown exposure [21,22]. In the U.S.,
numerous reports link insectivorous bats to the majority of human
rabies cases without a history of conventional exposure to RABV
[23]. During the same time period in Guatemala, despite detection
of over 200 cases of rabies in livestock, and suspected association of
such cases with vampire bat rabies, there were no reported cases in
bats.
Why RABV has not been detected in Guatemalan bats is
unclear, considering RABV has been detected in the majority of
bats species tested throughout North America [24]. Very few bats
are tested based upon the existing passive surveillance system, and
monoclonal antibody or genetic characterization of RABV
variants infecting humans, domestic animals and wildlife is not
performed. Given the nocturnal and somewhat cryptic nature of
bats, transmission dynamics are difficult to study in natural
populations, and many critical gaps remain for a basic
understanding the epizootiology of different RABV variants
maintained in specific bat taxa. In the present study, we report
results from field studies conducted in Guatemala from 2009–
2011. The objective of the study was to test whether enhanced
surveillance would: (1) complement passive surveillance, specifi-
cally regarding the presence of RABV in bats, and (2) extend
information on the geographic distribution of RABV circulation
among bats to assess the public and veterinary health risks
associated with bats in Guatemala.
Methods
Ethics statement
All animals were captured and handled in accordance with
national guidelines (Guide for the Care and Use of Laboratory
Animals) [25]. Protocols for animal capture and use were
approved by the CDC Animal Care and Use Committee (USA)
protocol number 1843 and 2096, and the Animal Care and Use
Committee of the Universidad del Valle de Guatemala (Guate-
mala).
Enhanced surveillance sampling
Guatemala was selected as one major comparative New World
study location as part of the U.S. Centers for Disease Control and
Prevention’s (CDC) Global Disease Detection (GDD) program
among ten international locations. The objective of the CDC
GDD program is to develop and strengthen global capacity to
rapidly detect, accurately identify, and promptly contain
emerging infectious threats. Nineteen field sites for sampling
bats in Guatemala were selected on the basis of historical
outbreaks of rabies, contemporary national surveillance data,
known or suspected vampire bat depredation upon human
populations, or neurological illness reported in livestock.
Figure 1a illustrates the geographical distribution of field sites
used in the present study. Bats were collected using mist nets set
near fruit trees, confined livestock, or near the entrance of caves.
Nets were opened between 19:00 to 0:00, and checked every
30 minutes. Bats were removed from mist nets, placed individ-
ually in cloth bags, and transported to a nearby temporary field
station, where they were sedated by a 0.05 to 0.1 mg
intramuscular injection of ketamine hydrochloride, oral/fecal
swabs obtained, and terminal blood samples were collected by
cardiac puncture under heavy anesthesia. Following euthanasia,
bats were identified to the level of species following a key for bats
of Costa Rica [26]. Standard morphological measurements were
also collected (e.g. gender, age, mass, and forearm length). A
complete necropsy was then performed on all bats, and samples
were stored immediately on dry ice in the field, and maintained
thereafter at 270uC in the laboratory at the Universidad del
Valle de Guatemala until shipment to the CDC Rabies
Laboratory in Atlanta, GA. Carcasses were banded and fixed
in 10% buffered formalin for several days, then permanently
transferred to 70% ethanol, for archival purposes.
Direct fluorescent antibody testing
Brain impressions prepared from frozen bat tissues were fixed in
acetone at 220uC, and RABV antigens were detected by the DFA
test, using fluorescein isothiocyanate (FITC)-labeled monoclonal
antibody (mAb) conjugate (Fujirebio Diagnostics, Inc., Malvern,
PA, USA), as described [27].
Serology
The presence of RABV neutralizing antibodies (rVNA) was
determined by the rapid fluorescent focus inhibition test (RFFIT)
or a modified micro-RFFIT test on sera collected from ten field
sites [28,29]. The rVNA titers of individual bats were calculated by
Author Summary
In this study we provide results of the first active and
extensive surveillance effort for rabies virus (RABV)
circulation among bats in Guatemala. The survey included
multiple geographic areas and multiple species of bats, to
assess the broader public and veterinary health risks
associated with rabies in bats in Guatemala. RABV was
isolated from vampire bats (Desmodus rotundus) collected
in two different locations in Guatemala. Sequencing of the
isolates revealed a closer relationship to Mexican and
Central American vampire bat isolates than to South
American isolates. The detection of RABV neutralizing
antibodies in 11 species, including insectivorous, frugivo-
rous, and sanguivorous bats, demonstrates viral circulation
in both hematophagous and non-hematophagous bat
species in Guatemala. The presence of bat RABV in rural
communities requires new strategies for public health
education regarding contact with bats, improved labora-
tory-based surveillance of animals associated with human
exposures, and novel techniques for modern rabies
prevention and control. Additionally, healthcare practi-
tioners should emphasize the collection of a detailed
medical history, including questions regarding bat expo-
sure, for patients presenting with clinical syndromes
compatible with rabies or any clinically diagnosed
progressive encephalitis.
Rabies in Bats, Guatemala
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the Reed-Muench method, and were converted to international
units (IU/mL) by comparison to a standard rabies immune
globulin (SRIG) control containing 2 IU/mL [30]. The SRIG titer
was generally higher in the micro-RFFIT test compared to the
standard RFFIT. For the objective of this study, positive rVNA
titers ($0.06 IU/mL) were defined by at least 50% neutralization
of the RABV challenge virus dose (50 focus forming doses) at a 1:5
dilution (RFFIT) or 1:10 dilution (micro-RFFIT). Final titers less
than 0.06 IU/mL were considered negative for the presence of
rVNA for the purposes of this investigation.
Figure 1. Map of selected field sites, Guatemala 2009–2011. (A) Yellow circles indicate the location 19 sites where bats were tested for RABV
antigen and circle size is proportional to the number of bats collected. (B) Red circles indicate the location of ten sites where sera were available for
rVNA testing and circle size is proportion to the level of rVNA seroprevalence among tested bats. The location of two rabies infected vampire bats (D.
rotundus) is indicated by green stars.
doi:10.1371/journal.pntd.0003070.g001
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Antigenic characterization
Antigenic characterization was performed by indirect immuno-
fluorescence using eight mAbs directed against the RABV
nucleoprotein (N) antigens (C1, C4, C9, C10, C12, C15, C18,
C19), supplied by EMD Millipore Corporation (Billerica, MA,
USA), as previously described [31]. Positive reactivity pattern
results were analyzed using previous described antigenic variant
patterns [32,33].
Virus isolation
Virus isolation was attempted on oral and fecal swabs stored
in growth medium (MEM-10), and organs, obtained from
DFA-positive bats. Homogenates (10% w/v) were prepared in
MagnaNA lyser tissue homogenizer tubes containing 1.4-mm
(diameter) ceramic beads (Roche Applied Science, Penzberg,
Germany), using 1.0 mL of MEM-10 as a diluent. The entire
solution from the oral swab, and 0.5 ml from the fecal swab was
used to inoculate cells for isolation. For virus recovery, 100 uL of
test inoculum was added to 1 mL of MEM-10 containing 56106
mouse neuroblastoma cells (MNA) in a T-25 tissue culture flask
(Corning, NY). Tissue culture flasks were incubated at 0.5% CO2
at 37uC for 72 hours. All cultures were sub-passaged a minimum
of four times. For infectivity assessments, Teflon-coated four well
slides were seeded with 30 uL of MEM-10 containing 0.56106
cells per mL, and incubated in a humid chamber at 0.5% CO2 at
Table 1. Bats collected for rabies testing from 19 field sites in Guatemala, 2009–2011.
Family Species Frequency (%)
Molossidae
Molossus sinaloae 2 (0.3)
Mormoopidae
Pteronotus davyi 20 (3.0)
Noctilionidae
Noctilio leporinus 1 (0.1)
Phyllostomidae
Artibeus jamaicensis 128 (19.0)
Artibeus lituratus 35 (5.2)
Artibeus phaeotis 10 (1.5)
Artibeus toltecus 2 (0.3)
Carollia brevicauda 2 (0.3)
Carollia castanea 2 (0.3)
Carollia perspicillata 30 (4.5)
Carollia sowelli 2 (0.3)
Centurio senex 1 (0.1)
Chiroderma salvini 6 (0.9)
Chiroderma villosum 1 (0.1)
Desmodus rotundus 200 (29.8)
Glossophaga soricina 47 (7.0)
Lasiurus ega 1 (0.1)
Macrophyllum macrophyllum 2 (0.3)
Micronycteris microtis 25 (3.7)
Phyllostomus discolor 14 (2.1)
Platyrrhinus helleri 18 (2.7)
Sturnira lilium 96 (14.3)
Sturnira ludovici 2 (0.3)
Trachops cirrhosus 1 (0.1)
Uroderma bilobatum 5 (0.7)
Vampyressa pusilla 2 (0.3)
Vampyrodes caraccioli 1 (0.1)
Vespertilionidae
Eptesicus fuscus 5 (0.7)
Myotis elegans 6 (0.9)
Myotis keaysi 1 (0.1)
Myotis nigricans 4 (0.6)
Total 672 (100)
doi:10.1371/journal.pntd.0003070.t001
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37uC for 24 hours. The slides were then rinsed with phosphate-
buffered saline (PBS 4550), and fixed in cold acetone at220uC for
one hour. RABV antigens were visualized by use of the DFA test,
using optimal working dilutions of FITC-labeled anti-RABV mAb
conjugate (Fujirebio Diagnostics, Inc., Malvern, PA, USA) after
each passage.
RNA extraction, reverse transcription, and PCR
Total RNA was extracted from fecal swabs and organ tissues of
RABV-infected bats using TRIZol reagent (Invitrogen, Carlsbad,
CA, USA). Fecal swabs were stored in 1 ml of MEM-10 in the
field, and 200 ml of the swab suspension was mixed with 1 ml of
TRIzol for RNA extraction. Primers were selected within the
coding region of the N gene and the initial reaction was
performed with sense primer 1066F, GARAGAAGATTCTT-
CAGRGA (positions 1157–1173), which was also used for reverse
transcription and antisense primer 304B, TTGACGAA-
GATCTTGCTCAT (positions 1514–1533). The hemi-nested
reaction was performed with sense primer 1087F, GAGAAR-
GAACTTCARGA (positions 1157–1173). The glycoprotein (G)
gene was amplified as two overlapping fragments using primer
combinations umf2/994b and 760f/308b, as previously described
[34]. All positions are given according to the Street Alabama
Dufferin RABV strain genome sequence (GenBank accession
number M31046). The RT-PCR was performed as described
elsewhere [35]. Positive results were confirmed by nucleotide
sequencing. RT-PCR products were purified with Wizard PCR
Preps DNA Purification System (Promega, Madison, WI, USA),
according to the manufacturer’s recommendations and se-
quenced in forward and reverse directions as described by [35],
using the Big Dye Terminator Cycle Sequencing Ready Reaction
Kit, version 1.1 on an ABI3770 sequencer (Applied Biosystems,
Carlsbad, CA, USA).
Phylogenetic analysis
The complete N and G sequences were assembled and
translated to amino acid sequences using the Bio Edit program
[36]. The dataset was supplemented with complete and partial
gene sequences available from GenBank and aligned in ClustalX
[37]. Table S1 describes details of all sequences used in this study,
including accession numbers, country of origin, year, and
specimen source. The GTR+I+G model were selected based on
the Bayesian factor and Akaike criterion evaluated in MEGA,
version 5.1. No molecular clock evaluation was implemented. The
analysis was performed using the Bayesian skyline population
prior, and two independent Markov Chain Monte Carlo (MCMC)
runs were performed with 1,000,000 iterations each. The results
were combined in Log Combiner, and the resulting maximum
clade credibility (MCC) tree generated with Tree Annotator using
20% for burn in and visualized in Fig Tree, version 1.4.0 [38].
Statistical analysis
All statistical analyses were performed using JMP version 9.0.2
or SAS version 9.2 (SAS Institute Inc., Cary, NC). The 95%
confidence intervals (CI) were calculated for proportions of
seropositive bats by species and location of capture. A nested
mixed logistic model was used to test the effect of trophic guild on
seroprevalence. Species nested within trophic guild was treated as
a random effect and trophic guild was treated as a fixed effect. As
only a single sanguivorous species was tested, we also compared
the model outputs with a data set excluding vampire bats. The
antibody prevalence between sex were also compared using x2
tests, and the level of significance was evaluated at a= 0.05.
Results
Geographic distribution of bat sampling
During 2009–2011, a total of 672 bats of 31 species were
collected from Guatemala. Bats were collected during 2009
(n = 220; Table S1), 2010 (n = 135; Table S2), and 2011
(n = 317; Table S3). Table 1 provides the details on the cumulative
frequency of capture by species. Among all captures, 56.3% were
male. The most frequently captured species was D. rotundus
(n = 200; 30%), followed by the Jamaican fruit bat, Artibeus
jamaicensis (n = 128; 19%) (Table 1).
Serologic evidence of RABV circulation in bats
From sera available for testing (n = 398), 28 bats demonstrated
detectable rVNA for an antibody prevalence of 7% (95% CI 5–
10%). Seroprevalence was highest for insectivorous species (21%),
followed by omnivorous (8%) and sanguivorous (9%) taxa. The
proportion of rVNA seropositive bats varied significantly across
trophic guilds in a complete data set (F3,20 = 4.65, p = 0.04; Species
(Diet)=3.4610221) and a data set without vampire bats
(F2,20 = 6.97, p = 0.005; Species (Diet)=4.4610
219). In both
models, pairwise contrasts revealed a significant difference
between frugivorous and insectivorous bats. Insectivorous bats
were 8.5 times as likely to be seropositive compared to frugivorous
bats. No other pairwise contrasts in rVNA seroprevalence between
trophic guild levels were significant. Among capture locations, the
proportion of seropositive bats was highest for Naranjo (21%),
followed by El Jobo (19%), and El Penate (11%). Table 2 provides
the details for individual bat species sampled by location and
trophic guild. Antibody prevalence between sexes was similar
(3.8% of males, 3.3% of females; P= 0.77). Species composition of
bats captured varied across sites (Table 2).
Detection of RABV and antigenic typing
RABV antigens were detected in the brain from two common
vampire bats. The bats were collected in El Pumpo, near the
Pacific Coast in the Department of Santa Rosa, and Palo Seco,
near the border with Mexico in the Department of San Marcos
(Figure 1b). The antigenic reaction pattern derived from the brain
specimens were consistent with RABV antigenic variant V3
associated with Desmodus rotundus (Table 3). Upon capture, one
of the two rabid bats demonstrated clinical signs consistent with
rabies infection. Additionally, this bat was dehydrated, in poor
physical condition, and had evidence of several bite wounds to its
body.
Isolation of RABV and detection of viral RNA by hemi-
nested reverse transcription-PCR
RABV was isolated in MNA cells 24 h after inoculation from
the kidney of one bat, and from oral swabs of both rabid bats.
Additional sub-passages revealed the presence of RABV in the
spleen of one bat, and the kidney and lung for both bats. RABV
was not isolated from the heart, liver, intestine, and fecal swabs.
Viral RNA was detected by hemi-nested RT-PCR in all specimens
examined, except the liver of Bat 321. The results of RABV
isolation and nucleic acid detection from tissues of rabid bats are
presented in Table 4.
GenBank accession numbers
In total, two RABV G sequences and two RABV N sequences
were generated from the brain tissues of infected bats in
this study and deposited into GenBank (accession numbers:
KF656696-99).
Rabies in Bats, Guatemala
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Molecular relationships between RABV associated with
vampire bats in Latin America
The N gene sequences of both viruses were 100% identical,
whereas the G sequences differed in one non-synonymous
substitution (302T,S). The viruses were most similar to one of the
lineages of vampire bat rabies viruses circulating in Mexico, and
were relatively distant from the lineages circulating in South
America, with the exception of Columbian lineages. The most
phylogenetically related viruses were described previously from
Chiapas, Tabasco and Veracruz states of eastern Mexico [39].
The only available vampire bat RABV N gene sequence from El-
Salvador (FJ228492) also clustered within this lineage (Figure 2, G
gene reconstruction not shown).
Discussion
Given the critical ecological importance of bats, especially in
tropical regions, novel strategies are necessary for the prevention
and control of bat-associated zoonoses. To our knowledge, this is
the first report and isolation of RABV from bats in Guatemala. In
this study, the prevalence of rabies among all collected bats was
low (0.3%), even among vampire bats (1%). The two vampire bat
RABV isolated were related phylogenetically to viruses associated
with vampire bats in the eastern states of Mexico and El Salvador,
which is not unexpected given their geographic proximity. Rabies
epizootics and phylogenetic clusters of RABV circulating in
vampire bat populations are relatively constrained in space
[40,41]. Previous phylogeographic studies suggested that vampire
bat rabies likely originated in the territory of Mexico [39]. If true,
these viruses may have been introduced to Guatemala and El
Salvador via eastern Mexico. The detection of rVNA from bats in
this study demonstrated RABV exposure among multiple species
of bats in Guatemala. The overall rVNA prevalence of 7% was
similar to other bat RABV surveillance studies conducted in Peru
(10.3%), Grenada (7.6%) and Trinidad (12.8%), but less than the
37% detection in Colima, Mexico [42–44]. Seroprevalence among
collection sites ranged from 0 to 21% among all bats, and 0 to
25% for D. rotundus, respectively. Our results are concordant with
previous studies in demonstrating that a substantial fraction of
apparently healthy bats have detectible rVNA, indicating previous
exposure to RABV, and suggesting clearance of peripheral
infection without clinical disease [42–44]. The presence of rVNA
only demonstrates prior exposure to RABV antigens, and does not
provide information about the timing, intensity, or frequency of
infection [45]. Furthermore, rVNA negative test results do not
guarantee a lack of exposure, and may vary according to the
selected cutoff value used for the serology test, as reviewed by
Gilbert et al. [46]. At a population level, the rVNA seroprevalence
data described here provide information about the cumulative
exposure history among all bats collected for each field site.
In experimentally infected bats, rVNA are typically generated
only among survivors, and bats that succumb to infection may
only seroconvert during late stages of clinical disease [45]. Similar
observations have been made regarding rVNA seroconversion in
human rabies patients [47]. Combined with antigen detection
results, rVNA seroprevalence data can be used to elucidate
infection dynamics in bat populations. Detection of RABV
excretion can provide meaningful insights for identifying potential
transmission pathways that can inform the structure of disease
dynamic models. In this study, the highest levels of virus were
consistently detected from oral swabs, kidney and lung tissue.
These results support primary secretion by oral routes, while
suggesting a possible pathway in urine (via the kidneys), which
warrants further investigation.
Strategies to control RABV transmitted by vampire bats in
Latin America have relied historically on population reduction
methods, either by non-specific destruction of roosts or by anti-
coagulants applied to cattle or individual bats. When the anti-
coagulant paste is applied to vampire bats, it is suspected that the
treated bats then return to a roost where is spread to other
conspecifics through allogrooming. Culling of vampire bats is
thought to benefit agriculture and public health in the short-term
by alleviating bat bites on livestock and humans respectively.
Figure 2. Maximum clade credibility tree of rabies viruses
based on complete nucleoprotein (N) gene sequences. Posterior
probabilities are shown for key nodes. Mexico dog RABV was used as an
out-group. Novel sequences generated from the CNS material of two
rabid vampire bats in this study are shown in red.
doi:10.1371/journal.pntd.0003070.g002
Rabies in Bats, Guatemala
PLOS Neglected Tropical Diseases | www.plosntds.org 8 July 2014 | Volume 8 | Issue 7 | e3070
However, there is little evidence that this method actually targets
rabid bats, and the apparent positive effect of culling on
seroprevalence, combined with demographic and behavioral
responses, may actually increase the proportion of susceptible
bats [41,48]. A recent report also suggests that it may be more
economically beneficial to support pre-exposure vaccination of
cattle, than rely on vampire bat culling [49].
Rabies surveillance at the national level in Guatemala falls
under the jurisdiction of the Ministry of Public Health and Social
Welfare [50]. Rabies control efforts in Guatemala are focused
primarily on mass vaccination of domestic dogs, which has led to a
significant decrease in human rabies cases, though it remains
unclear whether current efforts can achieve ultimate elimination of
canine rabies [21,51]. Indirect vaccination of vampire bats with
recombinant RABV vaccines have proven immunogenic and
efficacious in experimental infection models of D. rotundus,
though this strategy has not been tested in the field [52]. Despite
possibly reducing RABV infection of cattle, this strategy would not
eliminate the behavior or health and economic consequences (e.g.
secondary bacterial infections) of vampire bat depredation on
cattle. Interventions at the human-bat interface should be directed
at decreasing the risk of human exposure to bats by improved
educational campaigns on the risk of rabies associated with bats
and the importance of laboratory testing and prophylactic
treatment following exposures, as well as bat-proofing dwellings
where feasible [53]. Routine laboratory-based RABV surveillance
is necessary to properly evaluate any intervention strategy and
should include the submission and testing of all human and animal
cases involving bite contact with bats and other reservoir hosts. For
Guatemala, overcoming cold chain and transportation barriers
should be a priority to increase the proportion of contact cases that
are tested. To further elucidate the relative impacts of the urban or
sylvatic cycles on public health and agriculture, routine typing of
all positive rabies cases should be implemented. Rapid exchange of
information between sectors involved in human and animal rabies
surveillance and control is essential.
Unfortunately, despite significant progress in the prevention and
control of rabies, once clinical signs manifest in humans the case
fatality rate approaches 100%, even with intensive supportive care
[47]. However, appropriate post-exposure prophylaxis, including
immediate washing/flushing and disinfection of the wound and
prompt administration of RIG, and modern cell-culture vaccines
according to recommended vaccination schedules assures preven-
tion of rabies if bitten by a rabid bat [54]. Fortunately, modern cell
culture vaccines are readily available for both humans and animals
in Guatemala, and national authorities should provide pre-
exposure prophylaxis guidelines for persons or animals with
regular exposure to bats or other potential wildlife reservoirs (e.g.
carnivores).
As the first focused rabies study in Guatemala, gaps were
evident in our study. Limitations to the current study included a
lack of more focal seasonal sampling, a broader spatial scale, and a
need for greater engagement of the Ministries of Health and
Agriculture in a One Health context to improve routine laboratory
based surveillance. The presence of bat RABV in rural commu-
nities likely requires new strategies for joint public health and
veterinary education and outreach, increased availability for
diagnostic laboratory testing in remote areas, and continued
enhanced surveillance for rabies prevention and control, as
suggested for other developing countries [55,56]. Additional
studies at the human-bat interface would be useful to obtain
information on demographic characteristics (e.g. age, gender,
education) of persons exposed to bats, circumstances of bat
exposures (e.g. bites, scratches, skin contact), actions taken
following exposure, and knowledge of bat-borne zoonoses.
Previously, based upon ignorance or inaction, preventable human
rabies cases have occurred from bat exposure [57–59]. Given the
implications when such recommendations are not operative,
localities with a high risk for exposure to bats, and bat-borne
zoonoses, should be targeted in laboratory based surveillance
activities for the evaluation of robust, long-term prevention and
control strategies.
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Table S1. Bats collected for rabies testing from eight field sites in Guatemala, 2009. 
Species El Jobo El Penate La Viña Los Hilos Los Tarrales Montañas Azules Naranjo Salacuim Subtotal 
Artibeus jamaicensis 6  4 1   4 2 17 
Artibeus lituratus  1   2   4 7 
Artibeus toltecus     1    1 
Carollia castanea     1  1  2 
Carollia perspicillata 11 1  3 3    18 
Centurio senex        1 1 
Desmodus rotundus 10 2 6  4  13 21 56 
Glossophaga soricina 6  1 1 5  5 2 20 
Micronycteris microtis 3   22     25 
Myotis elegans 1      5  6 
Myotis nigricans 1        1 
Phyllostomus discolor     10    10 
Platyrrhinus helleri     2    2 
Pteronotus davyi    1   19  20 
Sturnira lilium 4 5 3 2 9 1 1 4 29 
Sturnira ludovici   1  1    2 
Trachops cirrhosus        1 1 
Vampyressa pusilla        2 2 
Total 42 9 15 30 38 1 48 37 220 
 
Table S2. Bats collected for rabies testing from two field sites in Guatemala, 2010. 
Species Agüero Montañas Azules Subtotal 
Artibeus jamaicensis 22 4 26 
Artibeus lituratus 2 3 5 
Artibeus phaeotis  1 1 
Artibeus toltecus 1  1 
Carollia perspicillata 6 2 8 
Desmodus rotundus 22 5 27 
Eptesicus fuscus 3 1 4 
Glossophaga soricina 8 8 16 
Macrophyllum macrophyllum 2  2 
Molossus sinaloae 2  2 
Myotis keaysi  1 1 
Myotis nigricans 1 1 2 
Platyrrhinus helleri 1 10 11 
Sturnira lilium 15 13 28 
Uroderma bilobatum 1  1 
Total 86 49 135 
 
Table S3. Bats collected for rabies testing from nine field sites in Guatemala, 2011. 
 
Species Don Israel Don Neto, El 
Pumpo  
Finca Don 
Hugo 
Finca 
Guadalupe 
Finca Las 
Conchas 
Finca Las 
Pavas 
Finca San 
Julian 
Palo 
Seco 
Finca El 
Pumpo 
Subtotal 
Artibeus jamaicensis  12 2 10 5 1 17 18 20 85 
Artibeus lituratus 3 2 2 6   3 1 6 23 
Artibeus phaeotis  2  3  1   3 9 
Carollia brevicauda    2      2 
Carollia perspicillata     1  3   4 
Carollia sowelli  2        2 
Chiroderma salvini  1 3 1   1   6 
Chiroderma villosum    1      1 
Desmodus rotundus  3 24 30 1 24 5 10 20 117 
Eptesicus fuscus      1    1 
Glossophaga soricina 1 2 1 3   1  3 11 
Lasiurus ega         1 1 
Myotis nigricans         1 1 
Noctilio leporinus         1 1 
Phyllostomus discolor  4        4 
Platyrrhinus helleri   1 1   2  1 5 
Sturnira lilium  8 9 11   9  2 39 
Uroderma bilobatum    1  1 2   4 
Vampyrodes caraccioli    1      1 
Total 4 36 42 70 7 28 43 29 52 317 
 
Table S4. List of nucleoprotein sequences included in the data set from Central and South American 
vampire bat RABV. 
 
Sequence  ID Country Year Specimen Source  
A13-0396 (KF656697) Guatemala 2012 Vampire bat  
A13-0465 (KF656696) Guatemala 2012 Vampire bat  
AB083809 Brazil 1998 Cattle  
AB297627 Brazil 2002 Neotropical fruit bat  
AB297632 Brazil 2002 Vampire bat  
AB519641 Brazil 1998 Great fruit-eating bat  
AB519642 Brazil 2000 Vampire bat  
AF045166 Peru 1996 Human  
AF070449 Brazil unknown Vampire bat  
AF351852 Trinidad 1995 Vampire bat  
AF352671 Paraguay 1994 Vampire bat  
AY854587 Mexico 1996 Vampire bat  
AY854589 Mexico 1990 Dog  
AY854592 Mexico 2000 Cow  
AY877433 Mexico 1990 Cow  
AY877434 Mexico 1995 Horse  
AY877435 Mexico 1993 Cow  
EF363728 Ecuador 2005 Human  
EF363733 Brazil 2005 Human  
EF428582 Brazil 2006 Vampire bat  
EU293113 Guyana 1990 Dog  
FJ228492 Salvador 2002 Human  
FJ228493 Mexico 2003 Cow  
GU991824 Mexico 2002 Vampire bat  
HM368179 Ecuador 2007 Cow  
JF693469 Columbia 2002 Horse  
JF693473 Columbia 1996 Cat  
JF693475 Columbia 1995 Human  
JQ685936 Mexico 2009 Vampire bat  
JQ685953 Mexico 2009 Vampire bat  
JX648424 Peru 2002 Horse  
KC758860 Argentina 1996 Cow  
KC758861 Argentina 2001 Cow  
U22478 French Guiana 1994 Dog  
 
